Why does it matter to get national experts in a room hosted by a patient advocacy group? Because the content is different. And equally important. Different perspectives to move the world 🏅🌎 AIM at Melanoma Foundation #WIM2024

Cancer emotions are complex, human behavior in the face of existential stress is complex, so many layers to why patients may withhold information or even intentionally lie, especially to docs in particular. (Patients: it’s ok, we get it) -Krista Rubin #WIM2024 AIM at Melanoma Foundation

Where we are so thankful for our teams - everyone from MAs to RNs to APPs to medical trainees - who help to add to the big picture of each patient and get them to the treatments they need and/or save them from the treatments they don’t actually want 🙏 #WIM2024 AIM at Melanoma Foundation

BRILLIANT well-being session at #WIM2024 by K Palamara McGrath. Absence of burnout DOES NOT equal well-being. “How do we take care of the people who take care of the people?” AIM at Melanoma Foundation

What an honor to spend an afternoon with leisha.emens, Society for Immunotherapy of Cancer president, discussing how women uniquely leverage networking and take on leadership, and how these styles differ in their reception from typical male patterns - the most thoughtful discussion of the day #wim2024

Dear Charis, You brought together a fierce passion for science, powerful and elegant grant writing, principled conduct in science medicine and collaboration, and strong endorsement of women in science. May Christmas carols and a terrific glass of wine be ever with you. With love.

Pauline Funchain Amanda Tilot (Komuro) Holly Pederson MD Lamis Yehia Charis Eng, MD, PhD Charis was true humanitarian, brilliant scientist, and great friend. She will truly be missed. It’s our job to carry forward what she taught us all to make the world a better and more fair place.

We lost a legend today. Jeff meant so much to the fields of melanoma and immuno-oncology. We were fortunate to learn from him and share the fruits of his labor with our patients. May his memory be a blessing.

Huge loss for this family, research community Cleveland Clinic Cleveland Clinic Lerner Research Institute Truly an amazing person, accomplished scientist with nearly 1700 publications, and a remarkable leader! Dedicated VeloSano supporter!! Deep condolences !!

ASPirE's first virtual meeting starting now! #irAE #community #research #advocacy

@JCO article demonstrating AI-based large language models to identify #irAEs among hospitalized patients ASCO #immunotherapy #ASPirE Pauline Funchain Kerry Reynolds ascopubs.org/doi/pdf/10.120…

Fantastic to join the amazing #ASPIRE virtual meeting with stellar colleagues across many countries to formulate our mission & vision statements & exchange ideas on how to tackle irAEs! Thanks Pauline Funchain #KerryReynolds & others for awesome leadership! Shailender Bhatia, MD Namrata Singh

🚨This Sat 9/7 starting at 9am PT by Zoom for virtual attendees and at 8am with registration/breakfast in person - the latest in melanoma information for patients and caregivers. Join us! AIM at Melanoma Foundation Stanford Cancer Institute

Good Morning Silicon Valley and extended melanoma fam 🌞 Kicking off the Living with Melanoma Symposium with Sam Guild, President of AIM at Melanoma Foundation 🖤 Looking forward to keynote from Alex Shoushtari, MD and talks from Allison Betof Warner, MD, PhD, Amanda Kirane and Susan Swetter 📚

Follow this 🧵 for updates on Living with Melanoma from AIM at Melanoma Foundation and Stanford Cancer Institute 👇

Never get tired of seeing the difference in stage IV melanoma now versus 15 years ago - from 6 month survival to 5 years+ Going over how we can make these numbers even better 💪 - Allison Betof Warner, MD, PhD at Living with Melanoma from AIM at Melanoma Foundation and Stanford Cancer Institute

Find yourself doctors (and colleagues) that get excited about moving the field forward like Alex Shoushtari, MD and Allison Betof Warner, MD, PhD Reunion of kindred spirits this morning at Living with Melanoma AIM at Melanoma Foundation and Stanford Cancer Institute

“No offense doc but what takes so long” - true and common story about how making progress in non-pharma cancer trials has so many obstacles between lack of access to funding, logistics, and people power by Alex Shoushtari, MD at Living with Melanoma AIM at Melanoma Foundation and Stanford Cancer Institute